IL115641A0 - Quinoxalines a process for their preparation and their use - Google Patents

Quinoxalines a process for their preparation and their use

Info

Publication number
IL115641A0
IL115641A0 IL11564195A IL11564195A IL115641A0 IL 115641 A0 IL115641 A0 IL 115641A0 IL 11564195 A IL11564195 A IL 11564195A IL 11564195 A IL11564195 A IL 11564195A IL 115641 A0 IL115641 A0 IL 115641A0
Authority
IL
Israel
Prior art keywords
alkoxy
quinoxalines
preparation
formula
carbonyl
Prior art date
Application number
IL11564195A
Other languages
English (en)
Inventor
Manfred Dr Roesner
Uta-Maria Billhardt-Troughton
Reinhard Dr Kirsch
Joerg-Peter Dr Kleim
Christoph Dr Meichsner
Guenther Dr Ries
Irvin Dr Winkler
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL115641A0 publication Critical patent/IL115641A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL11564195A 1994-10-19 1995-10-15 Quinoxalines a process for their preparation and their use IL115641A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4437406A DE4437406A1 (de) 1994-10-19 1994-10-19 Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
IL115641A0 true IL115641A0 (en) 1996-01-19

Family

ID=6531202

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11564195A IL115641A0 (en) 1994-10-19 1995-10-15 Quinoxalines a process for their preparation and their use

Country Status (27)

Country Link
US (1) US5723461A (pl)
EP (1) EP0708093B1 (pl)
JP (1) JPH08225544A (pl)
KR (1) KR960014108A (pl)
CN (1) CN1094930C (pl)
AT (1) ATE198747T1 (pl)
AU (1) AU708293B2 (pl)
BR (1) BR9504456A (pl)
CA (1) CA2160859A1 (pl)
CZ (1) CZ271295A3 (pl)
DE (2) DE4437406A1 (pl)
DK (1) DK0708093T3 (pl)
ES (1) ES2154311T3 (pl)
FI (1) FI954946A7 (pl)
GR (1) GR3035673T3 (pl)
HR (1) HRP950524B1 (pl)
HU (1) HUT73485A (pl)
IL (1) IL115641A0 (pl)
MY (1) MY132057A (pl)
NO (1) NO306615B1 (pl)
NZ (1) NZ280258A (pl)
PL (1) PL184860B1 (pl)
PT (1) PT708093E (pl)
SI (1) SI9500329A (pl)
SK (1) SK128495A3 (pl)
TW (1) TW328954B (pl)
ZA (1) ZA958783B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369057B1 (en) * 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
AU9318298A (en) * 1997-11-14 1999-06-07 Warner-Lambert Company Small molecule intervention in hiv-1 replication
GB9901795D0 (en) * 1999-01-28 1999-03-17 Glaxo Group Ltd Chemical compounds
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
US20030114385A1 (en) * 2001-04-27 2003-06-19 Cathers Brian E. Viral enzyme activated prototoxophores and use of same to treat viral infections
WO2005018531A2 (en) * 2003-08-26 2005-03-03 'chemical Diversity Research Institute', Ltd. Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
US7351709B2 (en) * 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
IN2014KN02601A (pl) 2012-04-24 2015-05-08 Vertex Pharma
SMT201900107T1 (it) 2013-03-12 2019-02-28 Vertex Pharma Inibitori della dna-pk
PL3424920T3 (pl) 2013-10-17 2020-11-16 Vertex Pharmaceuticals Incorporated Kokryształy (S)-N-metylo-8-(1-((2'-metylo-4’,6'-dideutero-[4,5'-bipirymidyn]-6-ylo)amino)propan-2-ylo)chinolino-4-karboksyamidu i ich deuterowane pochodne jako inhibitory DNA-PK
MX394860B (es) 2016-09-27 2025-03-24 Vertex Pharma Metodo para tratar cancer usando una combinacion de agentes que dañan adn e inhibidores de proteina cinasa dependiente de adn (adn-pk).
AU2022303386A1 (en) * 2021-07-02 2023-12-14 Aldeyra Therapeutics, Inc. Heterocyclic aldehyde trapping compounds and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164639T3 (es) * 1991-04-15 2002-03-01 Aventis Pharma Gmbh Quinoxalinas, procedimiento para su preparacion y su empleo.
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid

Also Published As

Publication number Publication date
SI9500329A (en) 1996-04-30
NZ280258A (en) 1997-09-22
PT708093E (pt) 2001-06-29
EP0708093A1 (de) 1996-04-24
DE4437406A1 (de) 1996-04-25
MY132057A (en) 2007-09-28
FI954946L (fi) 1996-04-20
FI954946A7 (fi) 1996-04-20
US5723461A (en) 1998-03-03
SK128495A3 (en) 1996-06-05
CA2160859A1 (en) 1996-04-20
ATE198747T1 (de) 2001-02-15
EP0708093B1 (de) 2001-01-17
HRP950524B1 (en) 2002-06-30
DE59508969D1 (de) 2001-02-22
DK0708093T3 (da) 2001-04-30
CN1094930C (zh) 2002-11-27
BR9504456A (pt) 1997-05-20
JPH08225544A (ja) 1996-09-03
FI954946A0 (fi) 1995-10-17
HU9503005D0 (en) 1995-12-28
ES2154311T3 (es) 2001-04-01
HRP950524A2 (en) 1997-10-31
GR3035673T3 (en) 2001-06-29
NO954139L (no) 1996-04-22
NO306615B1 (no) 1999-11-29
AU3431695A (en) 1996-05-02
TW328954B (en) 1998-04-01
CN1135483A (zh) 1996-11-13
ZA958783B (en) 1996-05-09
HUT73485A (en) 1996-08-28
PL311016A1 (en) 1996-04-29
NO954139D0 (no) 1995-10-18
CZ271295A3 (en) 1996-08-14
PL184860B1 (pl) 2003-01-31
AU708293B2 (en) 1999-07-29
KR960014108A (ko) 1996-05-22
HK1011988A1 (en) 1999-07-23

Similar Documents

Publication Publication Date Title
IL115641A0 (en) Quinoxalines a process for their preparation and their use
ES8602753A1 (es) Un procedimiento para la obtencion de agentes antibacteria- nos a base de acidos 7-amino-1-ciclopropil-6,8-difluor-1, 4-dihidro-4-oxo-3-quinolincarboxilicos
EP0342675A3 (en) Novel quinolonecarboxylic acid derivatives
HU9302696D0 (en) Process for producing aza quinoxaline derivatives and medical preparatives containing these compounds
EP0493608A4 (en) Quinolonecarboxylic acid derivative
ES8301962A1 (es) Un procedimiento para la produccion de un derivado de carboslivilo.
CY2125B1 (en) O-alkylated rapamycin derivatives and their use particularly as immunosuppressants
NZ290389A (en) Substituted pyrimidines typically substituted by -piperazin-1-yl
AU1485392A (en) Quinoxalines, processes for their preparation, and their use
IL118368A (en) N-oxide quinoxaline derivatives
MX9708696A (es) Cefalosporinas antibacterianas.
HUT73973A (en) Substituted benzol-sulfonyl-ureas and thioureas, process for producing them, pharmaceutical or diagnostical use of them and pharmaceutical compositions containing them
HU9400851D0 (en) Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2a]pyrazines
EP0487996A3 (en) Cephalosporins substituted in position 3, process for their preparation and their use as medicine
ES8603175A1 (es) Procedimiento para preparar derivados de benzotiazol
HU9502810D0 (en) Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments
PH31212A (en) 4-Amino-2-(hetero)aryl-butanamides useful as 5-HT1a-antagonists.
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.
MX9705390A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales.
ES459473A1 (es) Procedimiento para la preparacion de nuevas 9-alcohilamino- eritromicinas.
ZA908309B (en) Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives
ES2005749A6 (es) Procedimiento para preparar un compuesto de cefem.
PT87956A (pt) Processo para a preparacao de composicoes farmaceuticas anxioliticas contendo dosagens baixas de derivados de dioxopiperidina
MX9705214A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de hiperlipoproteinemia, hipertrigliceridemia, hiperlipidemia o hipercolesterolemia o arterioesclerosis o para el tratamiento anticoa
MX9705378A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad.